Belmont Medical Technologies Appoints Brian Larkin as Chief Executive Officer

Key Takeaways:

• Brian Larkin has been named CEO of Belmont Medical Technologies.
• The appointment is effective immediately, succeeding outgoing CEO Brian Ellacott.
• The announcement was made on February 3, 2026, in Billerica, Mass.
• Belmont specializes in fluid resuscitation and patient temperature management solutions.

Belmont Medical Technologies: A Brief Profile

Belmont Medical Technologies, based in Billerica, Massachusetts, focuses on advanced fluid resuscitation and patient temperature management solutions. Its commitment to healthcare innovation has positioned the company as a significant player in the medical technology industry.

A Seamless Leadership Transition

On February 3, 2026, Belmont announced that Brian Larkin would take the helm as Chief Executive Officer, effective immediately. He replaces former CEO Brian Ellacott in a smooth handover designed to ensure stability and continued growth.

Prioritizing Medical Advancements

Belmont Medical Technologies has made strides in providing vital healthcare tools, primarily in fluid resuscitation therapies and temperature management for patients. This focus aligns with the ongoing needs of hospitals and clinics that require reliable and efficient medical devices.

The Next Chapter

Although the full scope of Brian Larkin’s strategic vision remains to be seen, his appointment underscores Belmont’s intention to maintain and expand its role in the healthcare field. The company’s emphasis on innovative solutions promises to shape its future direction under Larkin’s leadership.